|
|
|||||||||
|
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: [email protected]. Type 508 Accommodation and the title of the report in the subject line of e-mail. Addendum: Vol. 47, No. RR-2In the MMWR Recommendations and Reports, "Public Health Service Task Force Recommendations for the Use of Antiretroviral Drugs in Pregnant Women Infected with HIV-1 for Maternal Health and for Reducing Perinatal HIV-1 Transmission in the United States," the following names should be added as persons who presented data at the Public Health Service Task Force meeting on May 9, 1997: Robert Coombs, MD, PhD; Rhoda Sperling, MD; David Shapiro, PhD; Miriam Poirer, PhD; Kenneth Ayers, DVM; and David Morse, PhD. Disclaimer All MMWR HTML versions of articles are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the electronic PDF version and/or the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices. **Questions or messages regarding errors in formatting should be addressed to [email protected].Page converted: 10/05/98 |
|||||||||
This page last reviewed 5/2/01
|